Technical Analysis for QLGN - Qualigen Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.87 | 0.26% | 0.01 |
QLGN closed up 0.26 percent on Wednesday, November 20, 2024, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.26% | |
| Narrow Range Bar | Range Contraction | 0.26% | |
| Wide Bands | Range Expansion | 0.26% | |
| Oversold Stochastic | Weakness | 0.26% |
| Alert | Time |
|---|---|
| Down 3% | about 22 hours ago |
| Down 2 % | about 22 hours ago |
| Down 1% | about 22 hours ago |
| Possible NR7 | 1 day ago |
| Lizard Bullish Entry | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Qualigen is a biotechnology company focused on developing novel products for the treatment and testing of cancer and infectious diseases. Its current commercial product is the FastPack rapid diagnostic testing system. This "Laboratory in a Pouch" is installed in physician offices, clinics and small hospitals around the world, and quickly detects diseases and medical conditions at the point-of-care. Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. Sekisui owns approximately 15.8% of Qualigen's outstanding common shares.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 39.13 |
| 52 Week Low | 3.3358 |
| Average Volume | 91,954 |
| 200-Day Moving Average | 12.91 |
| 50-Day Moving Average | 6.91 |
| 20-Day Moving Average | 4.64 |
| 10-Day Moving Average | 4.07 |
| Average True Range | 0.81 |
| RSI (14) | 30.56 |
| ADX | 48.19 |
| +DI | 10.75 |
| -DI | 22.44 |
| Chandelier Exit (Long, 3 ATRs) | 8.01 |
| Chandelier Exit (Short, 3 ATRs) | 5.77 |
| Upper Bollinger Bands | 6.00 |
| Lower Bollinger Band | 3.28 |
| Percent B (%b) | 0.22 |
| BandWidth | 58.73 |
| MACD Line | -0.98 |
| MACD Signal Line | -1.00 |
| MACD Histogram | 0.0173 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.44 | ||||
| Resistance 3 (R3) | 4.44 | 4.24 | 4.35 | ||
| Resistance 2 (R2) | 4.24 | 4.10 | 4.25 | 4.31 | |
| Resistance 1 (R1) | 4.06 | 4.01 | 4.15 | 4.06 | 4.28 |
| Pivot Point | 3.86 | 3.86 | 3.91 | 3.87 | 3.86 |
| Support 1 (S1) | 3.68 | 3.72 | 3.77 | 3.68 | 3.46 |
| Support 2 (S2) | 3.48 | 3.63 | 3.49 | 3.43 | |
| Support 3 (S3) | 3.30 | 3.48 | 3.40 | ||
| Support 4 (S4) | 3.30 |
